Navigating the IRA Webinar

Navigating the IRA: Reassessing Evidence for Price Negotiations

The signing of the Inflation Reduction Act (IRA) in 2022 marked a significant change in the U.S. health care ecosystem, particularly with the provision authorizing Centers for Medicare and Medicaid Services (CMS) to negotiate drug prices.

This webinar provides insights into CMS policy guidance around evidence considered while determining maximum fair prices (MFPs) and strategies to help manufacturers demonstrate true product value during Medicare price negotiations.

By attending this webinar, you will:

• Understand CMS’s initial policy guidance on evidence leveraged for negotiations with manufacturers and determining MFP
• Gain insight into Evidera’s value framework for positioning product value
• Explore strategies for developing robust evidence packages for future Medicare price negotiations

Speakers:

• Priya Jain, M.S., MBA, executive director, value and access
• Ariel Berger, MPH, executive director, integrated solutions, real-world evidence
• Sarah Ronnebaum, Ph.D., research scientist, evidence synthesis, modeling & communication

Guest speakers:

• Mark Fendrick, M.D., director, University of Michigan Center for Value-Based Insurance Design
• Manasee Shah, director, value, evidence & outcomes, GSK